Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline

[1]  D. Bennett,et al.  ADCS Prevention Instrument Project: Assessment of Instrumental Activities of Daily Living for Community-dwelling Elderly Individuals in Dementia Prevention Clinical Trials , 2006, Alzheimer disease and associated disorders.

[2]  D. Bennett,et al.  Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. , 2003, Archives of neurology.

[3]  W. Banks,et al.  Effect of dietary n-3 polyunsaturated fatty acids on brain lipid fatty acid composition, learning ability, and memory of senescence-accelerated mouse. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[4]  E. Nelson,et al.  Clinical Overview of Algal-Docosahexaenoic Acid: Effects on Triglyceride Levels and Other Cardiovascular Risk Factors , 2009, American journal of therapeutics.

[5]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[6]  L. Nalysnyk,et al.  DHA and cognitive function in the elderly: A systematic review of the literature , 2005, Alzheimer's & Dementia.

[7]  Vijaya L. Melnick,et al.  Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.

[8]  P. Maruff,et al.  Mild memory impairment in healthy older adults is distinct from normal aging , 2006, Brain and Cognition.

[9]  Steven G Heeringa,et al.  Prevalence of Cognitive Impairment without Dementia in the United States , 2008, Annals of Internal Medicine.

[10]  M. Gilewski,et al.  A 10-item Rasch modeled memory self-efficacy scale , 2004, Aging & mental health.

[11]  A. Folsom,et al.  Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. , 2007, The American journal of clinical nutrition.

[12]  Frank M LaFerla,et al.  Dietary Docosahexaenoic Acid and Docosapentaenoic Acid Ameliorate Amyloid-β and Tau Pathology via a Mechanism Involving Presenilin 1 Levels , 2007, The Journal of Neuroscience.

[13]  C. D. de Jager,et al.  Early detection of isolated memory deficits in the elderly: the need for more sensitive neuropsychological tests , 2002, Psychological Medicine.

[14]  Rhoda Au,et al.  Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. , 2006, Archives of neurology.

[15]  Takashi Morihara,et al.  A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model , 2005, The Journal of Neuroscience.

[16]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[17]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[18]  Hee-Yong Kim,et al.  Mechanisms of action of docosahexaenoic acid in the nervous system , 2001, Lipids.

[19]  L. Arterburn,et al.  Bioequivalence of Docosahexaenoic Acid from Different Algal Oils in Capsules and in a DHA-Fortified Food , 2007, Lipids.

[20]  Andrew D. Blackwell,et al.  Detecting Dementia: Novel Neuropsychological Markers of Preclinical Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.

[21]  Shih-Yi Huang,et al.  The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  T. Robbins,et al.  Early Detection and Differential Diagnosis of Alzheimer’s Disease and Depression with Neuropsychological Tasks , 2001, Dementia and Geriatric Cognitive Disorders.

[23]  Adriana M. Seelye,et al.  Status of computerized cognitive testing in aging: A systematic review , 2008, Alzheimer's & Dementia.

[24]  M. Lynch,et al.  Long-term potentiation in aged rats is restored when the age-related decrease in polyunsaturated fatty acid concentration is reversed. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[25]  S. Ferris,et al.  Age‐associated memory impairment: Proposed diagnostic criteria and measures of clinical change — report of a national institute of mental health work group , 1986 .

[26]  Yaakov Stern,et al.  Imaging hippocampal function across the human life span: Is memory decline normal or not? , 2002, Annals of neurology.

[27]  B. Heude,et al.  Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study. , 2003, The American journal of clinical nutrition.

[28]  R. Berecz,et al.  Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[29]  Lars-Olof Wahlund,et al.  Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. , 2006, Archives of neurology.

[30]  S. Nishiyama,et al.  Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: a PET study in conscious monkeys , 2000, Brain Research.

[31]  M. Tierney,et al.  Fatty acid analysis of blood plasma of patients with alzheimer's disease, other types of dementia, and cognitive impairment , 2000, Lipids.

[32]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[33]  J. Semple,et al.  Paired associate performance in the early detection of DAT , 2002, Journal of the International Neuropsychological Society.

[34]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[35]  L. Arterburn,et al.  Distribution, interconversion, and dose response of n-3 fatty acids in humans. , 2006, The American journal of clinical nutrition.

[36]  T. Mori,et al.  Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. , 1999, Hypertension.

[37]  K. Michaelsen,et al.  The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. , 2001, Progress in lipid research.

[38]  M. Stampfer,et al.  Cardiovascular disease and Alzheimer's disease: common links , 2006, Journal of internal medicine.

[39]  P. Rabbitt,et al.  Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. , 1994, Dementia.

[40]  D Kromhout,et al.  Dietary intake of fatty acids and fish in relation to cognitive performance at middle age , 2004, Neurology.